MYCOSES
Scope & Guideline
Unraveling the mysteries of fungal infections since 1957.
Introduction
Aims and Scopes
- Clinical Epidemiology of Fungal Infections:
Research on the prevalence, risk factors, and outcomes associated with various fungal infections, including candidemia, aspergillosis, and dermatophytoses, particularly in immunocompromised patients. - Antifungal Resistance Mechanisms:
Exploration of the mechanisms behind antifungal resistance in various fungal species, with a focus on genetic mutations and environmental factors contributing to increased resistance. - Diagnostic Innovations:
Development and evaluation of new diagnostic tools and methodologies, including molecular diagnostics, serological tests, and imaging techniques for early and accurate detection of fungal infections. - Treatment Strategies and Efficacy Studies:
Investigation of the efficacy of antifungal agents, including traditional therapies and novel treatments, in managing invasive fungal infections and their impact on patient outcomes. - Fungal Pathogenesis and Host Interactions:
Study of the interactions between fungal pathogens and host immune responses, including the role of specific immune cells and cytokines in the context of fungal infections. - Global Mycological Health Issues:
Assessment of the global burden of fungal diseases, their impact on public health, and the challenges faced in different geographical regions regarding diagnosis and treatment.
Trending and Emerging
- COVID-19-Associated Fungal Infections:
An increasing focus on the incidence and management of fungal infections related to COVID-19, particularly pulmonary aspergillosis and candidemia, as the pandemic has highlighted the vulnerability of certain patient populations. - Fungal Resistance Mechanisms and Management Strategies:
Heightened interest in understanding the molecular mechanisms of antifungal resistance and the development of novel antifungal agents or combination therapies to combat resistant strains. - Use of Advanced Diagnostics:
Growing trend towards the implementation of advanced diagnostic techniques such as PCR, next-generation sequencing, and artificial intelligence in the rapid detection and characterization of fungal pathogens. - Public Health and Global Burden of Fungal Diseases:
Increased emphasis on the global epidemiological burden of fungal diseases, with studies highlighting the need for improved public health strategies and awareness to combat these infections. - Exploration of Fungal Biofilms:
Emerging research on the role and impact of fungal biofilms in chronic infections and their resistance to treatment, indicating a shift towards understanding the complex nature of fungal pathogenesis.
Declining or Waning
- Traditional Dermatophyte Studies:
Research focusing solely on traditional dermatophytes, such as 'Trichophyton' and 'Microsporum', has seen a decrease as newer methodologies and a broader range of pathogens gain attention. - Basic Mycology without Clinical Relevance:
Studies that focus on basic mycological research without clear clinical applications or implications have become less prevalent, as researchers aim to bridge the gap between laboratory findings and clinical practice. - Single-Center Studies:
There is a noticeable reduction in the publication of single-center studies that lack broader epidemiological context, as multi-center and larger cohort studies are preferred for their generalizability. - Non-invasive Fungal Infections:
Research on non-invasive fungal infections has decreased, with a greater emphasis now placed on invasive fungal diseases and their management, particularly in immunocompromised populations.
Similar Journals
MYCOLOGIA
Innovative insights into fungal biology and ecology.MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.
Journal of Pediatric Infection
Championing the fight against pediatric infections.Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.
Mycosphere
Connecting researchers to the heart of fungal science.Mycosphere is a premier open-access journal published by MYCOSPHERE PRESS, dedicated to advancing the field of mycology and contributing significant insights into ecological and plant sciences. Established in 2010 and headquartered in Guiyang, China, this journal has carved out a vital niche, achieving remarkable rankings in the Scopus database—#3 in Ecology, Evolution, Behavior and Systematics and #4 in Plant Science, both boasting a 99th percentile ranking. With an unwavering commitment to disseminating high-quality research, Mycosphere serves as a critical platform for researchers, professionals, and students alike, encouraging robust dialogue and collaborations across the global scientific community. The journal's accessibility, coupled with its impact factor and Q1 categorizations in 2023 for both ecology and plant sciences, substantiate its role as an essential resource for cutting-edge studies and innovations in the field.
PARASITE IMMUNOLOGY
Pioneering Research on Host Responses to Parasites.PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.
Mycology-An International Journal On Fungal Biology
Fostering Collaboration in Fungal ResearchMycology: An International Journal on Fungal Biology, published by Taylor & Francis Ltd, stands at the forefront of fungal research, facilitating the dissemination of knowledge across the diverse fields of infectious diseases, microbiology, and plant science. Established as an Open Access journal since 2010, it offers researchers free and immediate access to high-quality articles that advance our understanding of fungal biology and its applications. With a commendable ranking in Q2 for Infectious Diseases and Microbiology, and Q1 for Plant Science as of 2023, it positions itself as a vital resource for the global scientific community. The journal, conveniently located in the United Kingdom, is committed to publishing rigorous research that stimulates discussion and fosters collaboration among academics, practitioners, and students alike. By providing a platform for innovative studies and critical reviews, Mycology continues to play an essential role in unraveling the complexities of fungal organisms and their profound implications in health, agriculture, and ecosystem dynamics.
MYCOSCIENCE
Bridging Science and Application in Fungal BiologyMYCOSCIENCE, published by the Mycological Society of Japan, is a prominent peer-reviewed journal that serves as an essential resource in the fields of ecology, evolution, behavior, and systematics, highlighted by its Q2 ranking in the 2023 category quartiles. Established in 1994 and continuing through 2024, the journal focuses on mycological research, providing insights into the interconnected worlds of fungi and their ecological roles. With an ISSN of 1340-3540 and an E-ISSN of 1618-2545, MYCOSCIENCE aims to disseminate high-quality research that addresses current issues and trends within the discipline. Despite not being an open-access journal, it makes a significant contribution to advancing fungal biology and its applications in agriculture and environmental science, making it an invaluable asset for researchers, professionals, and students alike. Located in the vibrant academic environment of Tokyo, Japan, MYCOSCIENCE stands out for its dedication to fostering a deeper understanding of mycology and its implications for biodiversity and ecosystem health.
MycoKeys
Elevating fungal knowledge for global ecological health.MycoKeys, published by PENSOFT PUBLISHERS, is a leading open-access journal dedicated to advancing the understanding of fungal biology and its diverse implications within agricultural, ecological, and biological sciences. With its ISSN 1314-4057 and E-ISSN 1314-4049, this journal has achieved remarkable academic prestige, reflected in its 2023 Scopus rankings placing it in the first quartile (Q1) across several categories, including Agricultural and Biological Sciences (miscellaneous), Ecology, Evolution, Behavior and Systematics, and Plant Science. MycoKeys provides a platform for researchers, professionals, and students interested in the latest findings and methodologies regarding fungi, their environments, and their interactions within various ecosystems. Since its transition to open access in 2011, the journal has championed the dissemination of high-quality research to a global audience, fostering collaboration and innovation in mycology. With a publishing history that converges from 2015 to 2024, MycoKeys remains a vital resource for those committed to exploring the multifaceted roles fungi play in our world.
MEDICAL MYCOLOGY
Bridging Science and Clinical Practice in MycologyMEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.
MYCOPATHOLOGIA
Fostering breakthroughs in veterinary microbiology.MYCOPATHOLOGIA, published by Springer in the Netherlands, stands as a pivotal journal in the fields of mycology, plant science, and veterinary microbiology. With its extensive history dating back to 1938, this journal has consistently contributed to the understanding of fungal pathogens and their impact on both agriculture and animal health. It currently holds impressive rankings in Scopus, including Q1 status in Agronomy and Crop Science, and Q2 rankings in Applied Microbiology and Biotechnology, demonstrating its influence and rigor in the scientific community. Researchers and professionals benefit from its curated, high-quality studies which address critical areas such as plant-pathogen interactions and veterinary mycology. While not open access, MYCOPATHOLOGIA emphasizes comprehensive research output and serves as a vital resource for advancing knowledge and fostering innovation in its disciplines. The journal remains committed to disseminating valuable insights that drive forward both academic inquiry and practical applications in related fields, ensuring its relevance and importance in contemporary research.
JOURNAL DE MYCOLOGIE MEDICALE
Connecting Science and Medicine in MycologyJOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.